Evolent Health, Inc. is −41% over the past year while the S&P 500 is +16%: 57 points behind the market. 1-year return: −41% (S&P 500 +16%). vs 200-day average: +24%, a clear uptrend. RSI (14): 72, overbought, bought harder than it has been sold. Below its 52-week high: 39%.

EVHEvolent Health, Inc.

Healthcare

$4.80-41% 1Y

$4.80

$2.1752 weeks$7.81

What is the market doing?

Mixed

No clear lean: in an uptrend, but heavily shorted (+11% of shares).

1 good, 1 to watch, 1 without data

TrendUptrendderived · Oct 23, 2026

In an uptrend, above its rising 50- and 200-day averages. Overbought (RSI 72). Price is +24% vs its 200-day average.

Short interest11% of sharesFINRA · Sep 30, 2026

Heavily shorted, settled Sep 30, 2026, about a week of normal trading to cover.

Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.

How EVH is trading

Evolent Health, Inc. is −41% over the past year while the S&P 500 is +16%: 57 points behind the market.

−41%

1-year return · S&P 500 +16%

vs 200-day average: +24%
vs 200-day average · a clear uptrend
RSI (14): 72
RSI (14) · overbought, bought harder than it has been sold
Below its 52-week high: 39%
Below its 52-week high

Oct 21, 2024$2.17 – $27.49 · dashed line: 200-day averageOct 23, 2026

Details›

Last close2026-10-23: $4.80
1 monthS&P 500 −0.94%: +37%
1 yearS&P 500 +16%: −41%
5 yearsS&P 500 +86%: −84%
vs 50-day average$4.22: +14%
52-week high: $7.81
52-week low: $2.17
Annualised volatility: 80%

Calendar-year price return
Year	Return
2026 (year to date)	+20%
2025	−64%
2024	−66%
2023	+18%
2022	+1.5%
2021	+73%
2020	+77%
2019	−55%
2018	+62%
2017	−17%

Average return by calendar month, 2016–2026
Month	Years	Positive	Average
Jan	10	5 of 10	+0.67%
Feb	10	7 of 10	+2.0%
Mar	10	4 of 10	−4.9%
Apr	10	8 of 10	+12%
May	10	4 of 10	−4.6%
Jun	10	7 of 10	+6.9%
Jul	11	6 of 11	+4.8%
Aug	11	8 of 11	+9.2%
Sep	11	5 of 11	−0.69%
Oct	11	2 of 11	−7.9%
Nov	10	3 of 10	−6.4%
Dec	10	4 of 10	−0.70%